Influence of Gestational Age on Fibrinolysis from Birth to Postnatal Day 10 - 20/08/11
, Philippe Leroux, PhD a, , Sophie Radi, MD c, Aude Ricbourg-Schneider, MD b, Vincent Laudenbach, MD, PhD a, c, Loïc Marpeau, MD, PhD b, Jacques Bénichou, MD, PhD d, Marc Vasse, PhD e, Stéphane Marret, MD, PhD a, cReprint requests: Dr Loïc Sentilhes, MD, PhD, Department of Obstetrics and Gynecology, Angers University Hospital, 4 rue Larrey, 49000 Angers, France.Abstract |
Objective |
To compare components of the fibrinolytic cascade in newborns of gestational age ranging from extreme prematurity to full term, at birth and for the next 10 days, and in their mothers at delivery.
Study design |
We studied 10 extremely preterm neonates, 10 very preterm neonates, 10 moderately preterm neonates, 10 full-term neonates, and their mothers (n = 40). We measured the antigen levels of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitors 1 (PAI-1) and 2 (PAI-2), and thrombin-activatable fibrinolysis inhibitor, as well as PAI-1 activity, in neonates at birth and on postnatal days 3 and 10 and in mothers at delivery.
Results |
On day 10, both PAI-1 antigen and activity were higher in extremely preterm neonates than in full-term neonates (P = .004 and <.0006, respectively), and the t-PA/PAI-1 activity ratio was lower in the extremely preterm and very preterm neonates compared with the full-term neonates (P = .002 and .017, respectively). No significant differences in the fibrinolytic system components were seen among the 4 groups of mothers.
Conclusions |
The development of fibrinolysis suppression in extremely preterm infants within 10 days after birth may contribute to the increased risk of periventricular hemorrhagic infarction in these infants.
Le texte complet de cet article est disponible en PDF.Mots-clés : ELISA, GMH-IVH, PAI, PVHI, TAFI, t-PA
Plan
| Supported by a 2005 grant from the Rouen University Hospital. The authors have no conflicts of interest to disclose. |
Vol 158 - N° 3
P. 377 - mars 2011 Retour au numéro
Article précédent
- 50 Years Ago in The Journal of Pediatrics : Turner’s Syndrome in the Male
- Erica A. Eugster, Alan D. Rogol
- Randomized Controlled Trial of Lung Lavage with Dilute Surfactant for Meconium Aspiration Syndrome
- Peter A. Dargaville, Beverley Copnell, John F. Mills, Ismail Haron, Jimmy K.F. Lee, David G. Tingay, Jaafar Rohana, Lindsay F. Mildenhall, Mei-Jy Jeng, Anushree Narayanan, Malcolm R. Battin, Carl A. Kuschel, Joel L. Sadowsky, Harshad Patel, Charles J. Kilburn, John B. Carlin, Colin J. Morley, on behalf of the lessMAS Trial Study Group ∗
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?